ASGITFSNSGMHW(Val-13C5,15N)R (TFA)
CAT:
804-HY-159046S
Size:
1 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No
ASGITFSNSGMHW(Val-13C5,15N)R (TFA)
- UNSPSC Description: ASGITFSNSGMHW(Val-13C5,15N)R TFA is an isotope of ASGITFSNSGMHWVR TFA labeled with 13C and 15N[1].
- Target Antigen: Isotope-Labeled Compounds
- Type: Isotope-Labeled Compounds
- Related Pathways: Others
- Field of Research: Others
- Assay Protocol: https://www.medchemexpress.com/asgitfsnsgmhw-val-13c5-15n-r-tfa.html
- Smiles: O=C(N[C@@H](CO)C(NCC(N[C@@H]([C@@H](C)CC)C(N[C@@H]([C@H](O)C)C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](CO)C(N[C@@H](CC(N)=O)C(N[C@@H](CO)C(NCC(N[C@@H](CCSC)C(N[C@@H](CC2=CNC=N2)C(N[C@@H](CC3=CNC4=CC=CC=C34)C([15NH][13C@@H]([13CH]([13CH3])[13CH3])[13C](N[C@@H](CCCNC(N)=N)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](C)N
- Molecular Weight: 1655.78 (free acid)
- References & Citations: [1]Russak E M, et al. Impact of deuterium substitution on the pharmacokinetics of pharmaceuticals[J]. Annals of Pharmacotherapy, 2019, 53(2): 211-216.
- Shipping Conditions: Room temperature
- Clinical Information: No Development Reported